A rapid review of COVID-19 vaccine prioritization in the U.S.: alignment between Federal guidance and State practice

Vageesh Jain, Lara Schwarz, Paula Lorgelly
doi: https://doi.org/10.1101/2021.03.11.21253411

Article Information

doi 
https://doi.org/10.1101/2021.03.11.21253411
History 
  • March 12, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Vageesh Jain1,*,
  2. Lara Schwarz2 and
  3. Paula Lorgelly3
  1. 1Institute for Global Health, University College London, UK
  2. 2Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA, USA
  3. 3Institute of Epidemiology and Health Care, University College London, UK
  1. ↵*Correspondence: Vageesh Jain, Vageesh.jain{at}ucl.ac.uk, +447551915006
Back to top
Posted March 12, 2021.
Download PDF
Data/Code
Email
A rapid review of COVID-19 vaccine prioritization in the U.S.: alignment between Federal guidance and State practice
Vageesh Jain, Lara Schwarz, Paula Lorgelly
medRxiv 2021.03.11.21253411; doi: https://doi.org/10.1101/2021.03.11.21253411
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area